CEO, Pharmaceutical Segment
Mon, Nov 27, 2023
Nov 27
5,990 shares @ $84.27
Increased holdings by +13.60%
Net across this filing: -20.40% (-9,000 shares)
11th largest trade (out of 31)
Option Exercise
Trade made by an officer
Sale tied to a same-time option exercise
Net holdings across this filing: -20.4% (-9,000 shares)
Insider trade was 21% below market price
Price 23% above 200-day moving average